Filed pursuant to Rule 424(b)(3)
                                                     Registration No. 333-133382


                                2,269,750 Shares


                             [LOGO OF NOBLE ROMAN'S]


                                  Common Stock

                 Prospectus Supplement No. 1 dated June 26, 2006
                      to the Prospectus dated May 18, 2006

         This prospectus supplement relates to the resale by the selling
shareholder, including its transferees, pledgees, donees or successors
identified in the prospectus of up to 2,269,750 shares of Noble Roman's, Inc.
common stock which is currently held by such selling shareholder. This
prospectus supplement should be read in conjunction with and may not be
delivered or utilized without our prospectus dated May 18, 2006, including any
amendments or supplements thereto.

         The shares are being registered to permit the selling shareholder to
sell the shares from time to time. The prices at which the selling shareholder
may sell the shares will be determined by the prevailing market price for the
shares or in negotiated transactions. We will not receive any of the proceeds
from the sale of shares of common stock by the selling shareholder, but will
bear the costs relating to the registration of the shares.

         The selling shareholder may sell the shares covered by this prospectus
from time to time through various means (e.g., in ordinary brokerage
transactions, directly to market makers for our shares, in negotiated
transactions or otherwise, at prevailing market prices). The selling shareholder
and any underwriters, agents, brokers or dealers through or to whom these shares
of common stock may be sold may be deemed "underwriters" of the shares within
the meaning of the Securities Act of 1933, as amended, in which event all
brokerage commissions or discounts and other compensation received by such
brokers or dealers may be deemed to be "underwriting compensation." If required,
the selling shareholder will disclose the names of any underwriter(s),
applicable commissions or discounts, and any other required information with
respect to any particular sales in an accompanying prospectus supplement.

         The selling securityholder has informed us that it has engaged C.L.
King & Associates, Inc. to act as its broker in connection with the sale of the
common stock offered by the prospectus. C.L. King & Associates, Inc. will be
entitled to a brokerage commission equal to $.03 per share of common stock sold.
The selling shareholder will pay commissions and selling expenses, if any,
incurred by it. The information is based on information provided by or on behalf
of the selling securityholders. Any changed information given to us by the
selling securityholders will be set forth in prospectus supplements if and when
necessary.

         Investing in the common stock involves risks. See "Risk Factors"
beginning on page 3 of the prospectus.

         Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or determined if the
prospectus or this prospectus supplement is truthful or complete. Any
representation to the contrary is a criminal offense.